Therapeutic Plasma Exchange in Pediatric Patients: Results from a Single Center

Overview

Journal J Pediatr Intensive Care

Date 2024 Dec 4

PMID 39629152

Authors

Tahir Dalkiran

Mehmet Mercan

Sevcan Ipek

Ufuk Utku Gullu

Yasar Kandur

Can Acipayam

Cengiz Dilber

Affiliations

Soon will be listed here.

Abstract

Therapeutic plasma exchange (TPE) can be applied as an effective therapeutic option in children with hematological, neurological, nephrological, and autoimmune/rheumatic disorders. We aimed to report our TPE experience in pediatric patients. In this article, we retrospectively reviewed the records of pediatric patients who underwent TPE between 2019 and 2021. A total of 128 TPE sessions were performed in 25 patients (13 males,12 females; mean age 59.6 ± 11.7 [3-198] months). The TPE indications were sepsis with/without multiorgan dysfunction syndrome in five patients, acute liver failure, hemolytic uremic syndrome caused by Shiga toxin, and autoimmune hemolytic anemia in three patients, respectively, multiple sclerosis, autoimmune encephalitis, and multisystem inflammatory syndrome in children (MIS-C) in two patients each, and myasthenia gravis crisis, meningococcemia, hemolytic uremic syndrome caused by coronavirus disease 2019, hemophagocytic lymphohistiocytosis, autoimmune encephalitis, and metabolic disease (fatty acid oxidation defect, liver failure) in one patient each. Based on our findings, we proposed that the American Society for Apheresis criteria should be updated according to newly described clinical conditions such as MIS-C.

References

Haque A, Sher G, Hoda M, Moiz B . Feasibility of pediatric plasma apheresis in intensive care settings. Ther Apher Dial. 2014; 18(5):497-501. DOI: 10.1111/1744-9987.12173. View

Keith P, Day M, Perkins L, Moyer L, Hewitt K, Wells A . A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19. Crit Care. 2020; 24(1):128. PMC: 7117947. DOI: 10.1186/s13054-020-2836-4. View

Churchwell K, McManus M, Kent P, Gorlin J, Galacki D, Humphreys D . Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia. J Clin Apher. 1995; 10(4):171-7. DOI: 10.1002/jca.2920100403. View

Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M . An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020; 395(10239):1771-1778. PMC: 7220177. DOI: 10.1016/S0140-6736(20)31103-X. View

Emeksiz S, Ozcan S, Perk O, Uyar E, Celikel Acar B, Kibar Gul A . Therapeutic plasma exchange: A potential management strategy for critically ill MIS-C patients in the pediatric intensive care unit. Transfus Apher Sci. 2021; 60(3):103119. DOI: 10.1016/j.transci.2021.103119. View

Ide K, Muguruma T, Shinohara M, Toida C, Enomoto Y, Matsumoto S . Continuous Veno-Venous Hemodiafiltration and Plasma Exchange in Infantile Acute Liver Failure. Pediatr Crit Care Med. 2015; 16(8):e268-74. DOI: 10.1097/PCC.0000000000000511. View

Aladjidi N, Leverger G, Leblanc T, Picat M, Michel G, Bertrand Y . New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica. 2011; 96(5):655-63. PMC: 3084911. DOI: 10.3324/haematol.2010.036053. View

Watson R, Crow S, Hartman M, Lacroix J, Odetola F . Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome. Pediatr Crit Care Med. 2017; 18(3_suppl Suppl 1):S4-S16. PMC: 5334773. DOI: 10.1097/PCC.0000000000001047. View

McLeod B . Therapeutic apheresis: history, clinical application, and lingering uncertainties. Transfusion. 2009; 50(7):1413-26. DOI: 10.1111/j.1537-2995.2009.02505.x. View

10.

Ilhan O, Uskent N, Arslan O, Arat M, Ozkalemkas F, Ozturk G . National survey of hemapheresis practice in Turkey (1998). Transfus Sci. 2000; 22(3):195-201. DOI: 10.1016/s0955-3886(00)00057-6. View

11.

Szczepiorkowski Z, Winters J, Bandarenko N, Kim H, Linenberger M, Marques M . Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher. 2010; 25(3):83-177. DOI: 10.1002/jca.20240. View

12.

Michon B, Moghrabi A, Winikoff R, Barrette S, Bernstein M, Champagne J . Complications of apheresis in children. Transfusion. 2007; 47(10):1837-42. DOI: 10.1111/j.1537-2995.2007.01405.x. View

13.

Novelli G, Rossi M, Morabito V, Pugliese F, Ruberto F, Perrella S . Pediatric acute liver failure with molecular adsorbent recirculating system treatment. Transplant Proc. 2008; 40(6):1921-4. DOI: 10.1016/j.transproceed.2008.05.075. View

14.

Hunt E, Jain N, Somers M . Apheresis therapy in children: an overview of key technical aspects and a review of experience in pediatric renal disease. J Clin Apher. 2013; 28(1):36-47. DOI: 10.1002/jca.21260. View

15.

Barcellini W . Current treatment strategies in autoimmune hemolytic disorders. Expert Rev Hematol. 2015; 8(5):681-91. DOI: 10.1586/17474086.2015.1073105. View

16.

Schwartz J, Padmanabhan A, Aqui N, Balogun R, Connelly-Smith L, Delaney M . Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016; 31(3):149-62. DOI: 10.1002/jca.21470. View

17.

Knaup H, Stahl K, Schmidt B, Idowu T, Busch M, Wiesner O . Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018; 22(1):285. PMC: 6206942. DOI: 10.1186/s13054-018-2220-9. View

18.

Nguyen T, Han Y, Kiss J, Hall M, Hassett A, Jaffe R . Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med. 2008; 36(10):2878-87. PMC: 2772176. DOI: 10.1097/ccm.0b013e318186aa49. View

19.

Busund R, Koukline V, Utrobin U, Nedashkovsky E . Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med. 2002; 28(10):1434-9. DOI: 10.1007/s00134-002-1410-7. View

20.

Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P . Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006; 108(4):1267-79. PMC: 1895874. DOI: 10.1182/blood-2005-10-007252. View